The Spectralis imaging platform by Heidelberg Engineering sets the standard in macular disease diagnostics.
A trusted choice for clinical studies worldwide, its multi-modal imaging – optical coherence tomography (OCT), OCT angiography (OCTA), and fundus imaging – enable early detection and precise monitoring of macular conditions.
TruTrack Active Eye Tracking uses anatomical landmarks for precise follow-up imaging with unmatched reproducibility, providing unparalleled consistency in monitoring disease progression. BluePeak autofluorescence with Region Finder enhances geographic atrophy (GA) measurement and management, offering clear visualisation of retinal pigment epithelium loss and lesion progression.
The modular design of Spectralis adapts to clinical needs, driving evidence-based treatment decisions and improving patient outcomes.
Contact: Heidelberg +61 3 9639 2125, Sales-AU@HeidelbergEngineering.com, www.HeidelbergEngineering.com
